RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Merida Biosciences

Merida Biosciences

Merida Biosciences develops precision treatments for autoimmune diseases.

Latest funding

$120M Series A ·

Led by Bain Capital Life Sciences · Source: startupintros.com

Funding history ↓

Acquired by EEli Lilly on for $2.9B · MSN.

Website: meridabio.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Life Science, Therapeutics.
Stage: Series A.
Based in: Cambridge, United States.
Founded: 2022.
Last round: May 7, 2025 · 558 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredJan 29, 2024 (2 years old)
About Merida Biosciences

The company uses a protein engineering platform to create Fc therapeutics. These therapeutics aim to selectively bind to specific antibodies.

TIMELINE · MONEY RAISED

Merida Biosciences | 464 days from website to first raise on record

Raised $120M in 1 sourced round·1 signal before the first raise
$30M$60M$90M$120MFEBJULDECMAYOCTMARAUG$120M||WEBSITE CREATED · JAN 29, 2024$120M Series A · May 7, 2025$120M A · MAY '25Acquired by Eli Lilly · Aug 31, 2026ACQUIRED BY ELI LILLY · AUG '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$120MBBain Capital Life Sciencesstartupintros.com

Timeline

  1. Acquired by EEli Lilly · $2.9B
    Source: MSN
  2. Website created

Founders and team

Investors

Companies like Merida Biosciences

Other companies backed by Bain Capital Life Sciences

Bain Capital Life Sciences portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/merida-biosciences (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy